Skip to content

Comparation of Individualized Homoeopathy and placebo combined with Yoga in management of Mild to Moderate Depressive Disorder in Adult Population.

Comparative Study of Individualized Homoeopathy and Placebo Combined with Yoga in Managing Mild to Moderate Depressive Disorder among Adult Population: A Randomized, Placebo Controlled Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077859
Enrollment
62
Registered
2024-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F338- Other recurrent depressive disorders

Interventions

Intervention1: Homoeopathic Medicine: Pill form 30 pill size oral route of administration centesimal scale First dose at the time of case taking Subsequent doses according to Follow ups Intervention2

Sponsors

Principal Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants included as per DSM-5 diagnostic criteria for depressive disorder. All genders of an adult age group from 18 years to 59 years. Participants who are ready to quit previous regimen.

Exclusion criteria

Exclusion criteria: Any form of severe systemic illness and immunocompromised participants will be excluded. Pregnant and lactating women. Substance Abuse, Other Mood disorder and other severe psychiatric disorders will be excluded. Participants who have taken any homoeopathic medicines in the past 3 months. Participants who refuses to give consent. Participants with severe and extreme depression will be excluded.

Design outcomes

Primary

MeasureTime frame
Changes will be observed on BDI-II Scale. Changes can be Positive, or Negative or No change.Timepoint: 15 Months Study 6 Months Enrollment 6 Months Follow up 3 Months Data Analysis first dose at the time of case taking subsequent doses according to follow ups. Beck’s Depression inventory scale to be used at the baseline and then 4 weeks,8 weeks,12 weeks upto 24 weeks.

Secondary

MeasureTime frame
N/ATimepoint: N/A

Countries

India

Contacts

Public ContactDr Kathika Chattopadhyay

Bakson Homoeopathic Medical college and Hospital

dr.kathika@gmail.com9910860193

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026